Loading...
Loading...
Of the 17 tracked institutions holding BBIO, 10 have a 3-year clone track record — 9 of them beat the S&P. Average holder's clone alpha: +5.1pt. It's a gauge of who owns the name, not just how many.
Among the 17 tracked institutional investors we monitor, BBIO (BRIDGEBIO PHARMA INC) is held with a combined value of $4.70B across 62,834,125 shares. The largest holder is VANGUARD GROUP INC with a position worth $1.29B (0.02% of their portfolio). 2 funds opened new positions in the most recent quarter. 9 funds increased their holdings. 6 funds reduced their position.
Total Institutional Value
$4.70B
Total Shares Held
62,834,125
Institutional Holders
17
% of Shares Outstanding
32.1%
of 195.86M shares · SEC 2026-04-30
Days to Cover
5.4+6.8%
25.75M shares short · FINRA 2026-07-15
Tracked 13F institutions hold 32.1% of BBIO's shares outstanding. This is a floor: 13F filings arrive on a ~45-day lag and we track only a subset of institutional filers, so true institutional ownership is higher. Shares-outstanding is the latest SEC cover-page figure (as of 2026-04-30), not a live float.
Ranked by estimated dollars moved (share change × implied price). 13F data lags up to 45 days.
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | $1.29B | 0.02% | +0.2% |
| 2 | BlackRock, Inc. | $1.06B | 0.02% | -2.3% |
| 3 | VIKING GLOBAL INVESTORS LP | $879.42M | 2.46% | -17.7% |
| 4 | STATE STREET CORP | $366.42M | 0.01% | -0.6% |
| 5 | PRICE T ROWE ASSOCIATES INC /MD/ | $282.31M | 0.03% | -0.7% |
| 6 | CITADEL ADVISORS LLC | $235.70M | 0.17% | +354.6% |
| 7 | WELLINGTON MANAGEMENT GROUP LLP | $184.46M | 0.03% | +5.8% |
| 8 | FMR LLC | $174.05M | 0.01% | -1.9% |
| 9 | Capital Research Global Investors | $56.71M | 0.01% | -60.5% |
| 10 | MILLENNIUM MANAGEMENT LLC | $47.03M | 0.02% | +1631.0% |
| Member | Type | Date |
|---|---|---|
| Gilbert Cisneros | Buy | May 11, 2026 |
| Gilbert Cisneros | Buy | Apr 29, 2026 |
| Gilbert Cisneros | Buy | Mar 19, 2026 |
| Gilbert Cisneros | Buy |
As of the latest SEC 13F filings, VANGUARD GROUP INC is the largest institutional holder of BBIO with a position worth $1.29B, representing 0.02% of their portfolio. In total, 17 institutional investors hold BBIO with a combined value of $4.70B.
In the most recent quarter, 2 funds opened a new position in BBIO. Additionally, 9 increased their holdings and 6 reduced their positions.
Institutional investors hold $4.70B worth of BBIO stock across 17 positions. The largest institutional holder is VANGUARD GROUP INC with $1.29B in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For BBIO, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their BBIO positions.
Alpha = the manager's 3-year clone return minus the S&P 500. A skilled roster is a stronger tell than a crowded one — though even skilled managers' edge doesn't reliably survive the 13F disclosure lag. Why →
| Mar 18, 2026 |
| Gilbert Cisneros | Buy | Mar 3, 2026 |
| Gilbert Cisneros | Buy | Sep 22, 2025 |
| Gilbert Cisneros | Buy | Aug 8, 2025 |
Last Close
$84.02
2026-07-24
YTD
+7.4%
86% of 52-week range